GEMCITABINE

GEMCITABINE was reported 54063 times

GEMCITABINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NON-RENAL CELL CARCINOMA OF KIDNEY 15 0.6522
1 DESMOPLASTIC SMALL ROUND CELL TUMOUR 36 0.4138
2 REFRACTORY CANCER 51 0.2383
3 PSEUDOCELLULITIS 50 0.2336
4 PLATELET TOXICITY 19 0.2065
5 PSEUDOCIRRHOSIS 68 0.2048
6 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 333 0.1509
7 DUCTAL ADENOCARCINOMA OF PANCREAS 40 0.1444
8 BILIARY TRACT INFECTION 83 0.1334
9 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 125 0.1320
10 RECALL PHENOMENON 102 0.1220
11 CHOLANGITIS INFECTIVE 28 0.1053
12 PANCREATIC CARCINOMA RECURRENT 25 0.1037
13 BILIARY SEPSIS 45 0.0972
14 PANCREATIC CARCINOMA METASTATIC 269 0.0945
15 METASTASES TO RETROPERITONEUM 16 0.0941
16 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 21 0.0913
17 METASTASES TO MUSCLE 16 0.0884
18 PIK3CA-ACTIVATED MUTATION 29 0.0873
19 HIGH-GRADE B-CELL LYMPHOMA 16 0.0856
20 HAEMOLYTIC URAEMIC SYNDROME 185 0.0797
21 PANCREATIC ABSCESS 16 0.0792
22 TOXIC ERYTHEMA OF CHEMOTHERAPY 19 0.0734
23 THROMBOTIC MICROANGIOPATHY 704 0.0722
24 CONGENITAL APLASIA 22 0.0707
25 ADENOCARCINOMA PANCREAS 89 0.0693
26 METASTASES TO BONE MARROW 32 0.0640
27 ADENOVIRAL HEPATITIS 15 0.0638
28 HYPERCALCAEMIA OF MALIGNANCY 17 0.0625
29 CHOLANGITIS 381 0.0614
30 METASTASES TO SPLEEN 25 0.0605
31 FOLLICULAR LYMPHOMA 52 0.0591
32 METASTASES TO PERITONEUM 146 0.0578
33 METASTASES TO CHEST WALL 20 0.0576
34 CAPILLARY LEAK SYNDROME 119 0.0575
35 DUODENAL OBSTRUCTION 17 0.0567
36 HAEMATOTOXICITY 520 0.0547
37 EGFR GENE MUTATION 20 0.0535
38 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 43 0.0529
39 DUODENAL STENOSIS 24 0.0494
40 CHOLANGIOCARCINOMA 71 0.0477
41 DIFFUSE LARGE B-CELL LYMPHOMA 365 0.0473
42 CARBOHYDRATE ANTIGEN 19-9 INCREASED 25 0.0473
43 HEPATITIS B CORE ANTIBODY POSITIVE 17 0.0451
44 OVARIAN CANCER METASTATIC 38 0.0447
45 POST THROMBOTIC SYNDROME 20 0.0444
46 B-CELL LYMPHOMA RECURRENT 24 0.0442
47 LEIOMYOSARCOMA 17 0.0442
48 METASTASES TO THE MEDIASTINUM 18 0.0437
49 METASTATIC LYMPHOMA 17 0.0435
50 METASTASES TO SKIN 43 0.0416
51 BONE MARROW INFILTRATION 16 0.0413
52 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 32 0.0406
53 CHOLANGITIS ACUTE 30 0.0397
54 STENT OCCLUSION 21 0.0395
55 DISEASE PROGRESSION 4646 0.0392
56 NEUTROPENIC SEPSIS 279 0.0390
57 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 30 0.0384
58 BILE DUCT STENOSIS 45 0.0375
59 AORTIC THROMBOSIS 42 0.0363
60 DRY GANGRENE 23 0.0362
61 METASTASES TO ABDOMINAL CAVITY 17 0.0346
62 OVARIAN CANCER RECURRENT 55 0.0342
63 BILIARY OBSTRUCTION 44 0.0339
64 METASTASES TO PLEURA 35 0.0334
65 BLADDER CANCER RECURRENT 33 0.0331
66 LIVER ABSCESS 106 0.0326
67 MALIGNANT ASCITES 25 0.0326
68 BONE MARROW TOXICITY 38 0.0321
69 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 19 0.0320
70 METASTASES TO PELVIS 20 0.0316
71 GASTROINTESTINAL TOXICITY 151 0.0314
72 THERAPY PARTIAL RESPONDER 485 0.0311
73 METASTASES TO LUNG 347 0.0300
74 METASTASES TO LIVER 520 0.0296
75 NEUTROPENIC INFECTION 27 0.0282
76 ENTEROCOLITIS INFECTIOUS 26 0.0282
77 METASTASES TO ADRENALS 26 0.0282
78 PERITONEAL DISORDER 18 0.0278
79 TRANSITIONAL CELL CARCINOMA 36 0.0277
80 METASTASES TO LYMPH NODES 187 0.0277
81 THROMBOCYTOPENIA 3043 0.0272
82 PERIPHERAL SENSORY NEUROPATHY 159 0.0272
83 VENA CAVA THROMBOSIS 45 0.0271
84 HYPERTRANSAMINASAEMIA 187 0.0269
85 ANISOCYTOSIS 17 0.0259
86 CHRONIC MYELOMONOCYTIC LEUKAEMIA 17 0.0258
87 OBSTRUCTION GASTRIC 33 0.0256
88 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 45 0.0253
89 EXTREMITY NECROSIS 44 0.0252
90 SYSTEMIC INFECTION 41 0.0247
91 KLEBSIELLA TEST POSITIVE 16 0.0246
92 MYCOSIS FUNGOIDES 20 0.0243
93 RETINAL TOXICITY 25 0.0243
94 THROMBOTIC THROMBOCYTOPENIC PURPURA 84 0.0238
95 CYTOPENIA 289 0.0236
96 NEOPLASM RECURRENCE 80 0.0236
97 CYTOKINE RELEASE SYNDROME 472 0.0235
98 BILE DUCT OBSTRUCTION 42 0.0221
99 LYMPHANGIOSIS CARCINOMATOSA 23 0.0221
100 MUSCLE NECROSIS 20 0.0220
101 LYMPHADENOPATHY MEDIASTINAL 41 0.0214
102 FEBRILE NEUTROPENIA 1407 0.0212
103 LYMPHANGITIS 17 0.0211
104 DISSEMINATED CRYPTOCOCCOSIS 16 0.0211
105 MALIGNANT NEOPLASM PROGRESSION 2153 0.0210
106 MYOSITIS 187 0.0208
107 CATHETER RELATED INFECTION 21 0.0207
108 OTOTOXICITY 38 0.0205
109 PULMONARY TOXICITY 145 0.0205
110 KLEBSIELLA SEPSIS 23 0.0204
111 IMMUNE-MEDIATED HEPATITIS 41 0.0201
112 NEUTROPENIA 2703 0.0199
113 ALVEOLITIS 28 0.0198
114 CARBOHYDRATE ANTIGEN 15-3 INCREASED 15 0.0197
115 PERFORMANCE STATUS DECREASED 92 0.0197
116 MUCOSAL INFLAMMATION 515 0.0197
117 TUMOUR LYSIS SYNDROME 173 0.0196
118 THROMBOCYTOSIS 72 0.0196
119 PERIPHERAL ISCHAEMIA 80 0.0196
120 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 114 0.0192
121 SYSTEMIC CANDIDA 48 0.0191
122 LEUKOPENIA 945 0.0189
123 BICYTOPENIA 37 0.0189
124 NEOPLASM PROGRESSION 653 0.0188
125 PERIPHERAL MOTOR NEUROPATHY 26 0.0185
126 HYPOALBUMINAEMIA 144 0.0185
127 METASTASES TO MENINGES 42 0.0185
128 SUBCLAVIAN VEIN THROMBOSIS 21 0.0184
129 PANCYTOPENIA 1024 0.0183
130 ESCHERICHIA BACTERAEMIA 42 0.0178
131 PANCREATIC MASS 19 0.0178
132 SKIN TOXICITY 100 0.0177
133 METASTASES TO BONE 287 0.0175
134 PELVIC VENOUS THROMBOSIS 25 0.0174
135 ADENOCARCINOMA 39 0.0174
136 METASTASIS 124 0.0174
137 TUMOUR PSEUDOPROGRESSION 19 0.0174
138 BLOOD LACTATE DEHYDROGENASE INCREASED 272 0.0171
139 TUMOUR NECROSIS 18 0.0170
140 MYELITIS TRANSVERSE 24 0.0170
141 NEUROTOXICITY 297 0.0169
142 NON-SMALL CELL LUNG CANCER 81 0.0169
143 IMMUNE-MEDIATED DERMATITIS 17 0.0169
144 BONE MARROW FAILURE 342 0.0168
145 METASTASES TO CENTRAL NERVOUS SYSTEM 217 0.0168
146 EMBOLISM 139 0.0167
147 BREAST CANCER METASTATIC 177 0.0165
148 MYELOSUPPRESSION 590 0.0164
149 POLYNEUROPATHY 196 0.0164
150 PNEUMONITIS 444 0.0163
151 ESCHERICHIA SEPSIS 47 0.0162
152 MYELODYSPLASTIC SYNDROME 234 0.0162
153 GENE MUTATION 32 0.0162
154 JAUNDICE CHOLESTATIC 57 0.0161
155 HYPERAMMONAEMIC ENCEPHALOPATHY 28 0.0161
156 HEPATIC MASS 31 0.0161
157 HYPERPYREXIA 68 0.0160
158 ENTEROCOCCAL BACTERAEMIA 17 0.0160
159 SMALL INTESTINAL PERFORATION 30 0.0160
160 NEUTROPHIL COUNT ABNORMAL 45 0.0159
161 CYSTOID MACULAR OEDEMA 30 0.0159
162 EMBOLISM ARTERIAL 19 0.0158
163 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 42 0.0158
164 OSTEOLYSIS 32 0.0156
165 ACUTE MYELOID LEUKAEMIA 244 0.0156
166 RENAL TUBULAR INJURY 19 0.0156
167 ASCITES 459 0.0156
168 METASTASES TO SPINE 52 0.0155
169 OCULAR TOXICITY 17 0.0154
170 CYTOMEGALOVIRUS CHORIORETINITIS 30 0.0154
171 OSTEOSCLEROSIS 24 0.0152
172 SARCOMA 17 0.0150
173 AZOTAEMIA 60 0.0150
174 HYPERSENSITIVITY PNEUMONITIS 17 0.0149
175 HEPATIC INFECTION 19 0.0149
176 LYMPHOMA 228 0.0147
177 ACUTE PROMYELOCYTIC LEUKAEMIA 15 0.0146
178 ACQUIRED GENE MUTATION 19 0.0145
179 TUMOUR PAIN 19 0.0144
180 HYPERPHOSPHATAEMIA 31 0.0144
181 METASTATIC NEOPLASM 62 0.0144
182 BILE DUCT CANCER 17 0.0143
183 MALIGNANT PLEURAL EFFUSION 24 0.0142
184 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 331 0.0142
185 NORMOCHROMIC NORMOCYTIC ANAEMIA 42 0.0140
186 BACTERAEMIA 165 0.0139
187 NEPHROPATHY TOXIC 156 0.0139
188 CEREBRAL ISCHAEMIA 71 0.0138
189 SPLENIC INFARCTION 24 0.0137
190 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 131 0.0137
191 CARDIOTOXICITY 122 0.0137
192 HYPERBILIRUBINAEMIA 141 0.0136
193 BILIARY DILATATION 20 0.0136
194 COMPUTERISED TOMOGRAM ABNORMAL 30 0.0132
195 IMMUNE-MEDIATED ADVERSE REACTION 20 0.0130
196 BILIARY TRACT DISORDER 18 0.0130
197 ANAEMIA 2483 0.0130
198 EMBOLISM VENOUS 39 0.0128
199 PERIPHERAL ARTERY OCCLUSION 18 0.0128
200 FEBRILE INFECTION 15 0.0127
201 PORTAL VEIN THROMBOSIS 41 0.0127
202 PORTAL HYPERTENSION 39 0.0126
203 SUBILEUS 26 0.0125
204 URINARY TRACT OBSTRUCTION 29 0.0122
205 DRUG RESISTANCE 312 0.0121
206 INVASIVE DUCTAL BREAST CARCINOMA 33 0.0121
207 ABDOMINAL INFECTION 31 0.0121
208 PERIPHERAL ARTERY THROMBOSIS 17 0.0121
209 PNEUMOCYSTIS JIROVECII PNEUMONIA 121 0.0120
210 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 15 0.0120
211 SOFT TISSUE INFECTION 22 0.0120
212 HEPATIC CYTOLYSIS 152 0.0119
213 CUTANEOUS T-CELL LYMPHOMA 15 0.0119
214 ENTERITIS 75 0.0117
215 NEUTROPHIL COUNT DECREASED 477 0.0117
216 PSEUDOMONAL SEPSIS 20 0.0114
217 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 15 0.0114
218 FAILURE TO THRIVE 59 0.0114
219 IMMUNE-MEDIATED HEPATIC DISORDER 22 0.0113
220 HEPATORENAL SYNDROME 19 0.0112
221 ORAL INTAKE REDUCED 27 0.0112
222 LARYNGOSPASM 30 0.0111
223 CELL DEATH 22 0.0111
224 DYSAESTHESIA 34 0.0111
225 BREAST CANCER RECURRENT 35 0.0111
226 KLEBSIELLA INFECTION 56 0.0111
227 GASTROINTESTINAL PERFORATION 46 0.0111
228 IMMUNE-MEDIATED LUNG DISEASE 20 0.0110
229 LUNG ADENOCARCINOMA 33 0.0110
230 FEBRILE BONE MARROW APLASIA 46 0.0108
231 NEUROPATHY PERIPHERAL 1017 0.0107
232 MIXED LIVER INJURY 32 0.0106
233 UROSEPSIS 98 0.0106
234 LEFT VENTRICULAR DYSFUNCTION 71 0.0106
235 ENTEROCOLITIS 61 0.0106
236 IMMUNE-MEDIATED MYOCARDITIS 17 0.0105
237 PLEURAL EFFUSION 635 0.0104
238 HEPATOTOXICITY 231 0.0104
239 MULTIPLE-DRUG RESISTANCE 32 0.0103
240 MENINGITIS CRYPTOCOCCAL 18 0.0103
241 GRAFT VERSUS HOST DISEASE 73 0.0101
242 ISCHAEMIA 46 0.0100
243 HEPATIC LESION 43 0.0099
244 VENOUS THROMBOSIS 39 0.0099
245 ORGANISING PNEUMONIA 49 0.0099
246 LYMPHOEDEMA 67 0.0097
247 LYMPHOPENIA 137 0.0097
248 NEUTROPENIC COLITIS 20 0.0097
249 JUGULAR VEIN THROMBOSIS 17 0.0095
250 LUNG OPACITY 25 0.0095
251 CARDIAC TAMPONADE 45 0.0095
252 SMALL INTESTINAL OBSTRUCTION 116 0.0094
253 SECOND PRIMARY MALIGNANCY 78 0.0094
254 TRANSAMINASES INCREASED 208 0.0093
255 HYDRONEPHROSIS 70 0.0093
256 RECURRENT CANCER 38 0.0093
257 LYMPHOCYTOSIS 20 0.0093
258 PROTEINURIA 174 0.0091
259 GASTROINTESTINAL OBSTRUCTION 22 0.0091
260 THROMBOPHLEBITIS 32 0.0091
261 DISEASE RECURRENCE 434 0.0091
262 URINARY TRACT INFECTION BACTERIAL 23 0.0091
263 DERMATITIS ACNEIFORM 55 0.0090
264 LUNG CANCER METASTATIC 26 0.0090
265 INFECTED SKIN ULCER 17 0.0090
266 HYPOPROTEINAEMIA 17 0.0090
267 VENOOCCLUSIVE LIVER DISEASE 44 0.0089
268 ATELECTASIS 86 0.0089
269 BONE LESION 32 0.0089
270 SEPTIC SHOCK 381 0.0087
271 CYSTITIS HAEMORRHAGIC 35 0.0087
272 PANNICULITIS 21 0.0087
273 RED CELL DISTRIBUTION WIDTH INCREASED 36 0.0087
274 HYPOPHOSPHATAEMIA 64 0.0087
275 OPPORTUNISTIC INFECTION 16 0.0086
276 GRANULOCYTE COUNT DECREASED 16 0.0086
277 LUNG INFILTRATION 76 0.0086
278 ABDOMINAL MASS 23 0.0086
279 ACUTE RESPIRATORY DISTRESS SYNDROME 151 0.0085
280 STAPHYLOCOCCAL BACTERAEMIA 37 0.0085
281 HAEMOLYTIC ANAEMIA 76 0.0085
282 SKIN NECROSIS 44 0.0085
283 RENAL COLIC 19 0.0084
284 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 32 0.0084
285 BLOOD BILIRUBIN INCREASED 226 0.0084
286 BREAST DISORDER 17 0.0083
287 ARTERIAL THROMBOSIS 16 0.0083
288 BONE MARROW DISORDER 25 0.0083
289 PANCREATIC CARCINOMA 238 0.0082
290 LUNG CONSOLIDATION 23 0.0082
291 HYPOMAGNESAEMIA 114 0.0082
292 APLASIA 16 0.0082
293 GASTRIC PERFORATION 22 0.0081
294 ENTEROCOCCAL INFECTION 39 0.0081
295 ARTERIOSPASM CORONARY 32 0.0080
296 SMALL INTESTINAL HAEMORRHAGE 16 0.0079
297 SEPSIS 885 0.0079
298 TUMOUR MARKER INCREASED 38 0.0079
299 PERICARDIAL EFFUSION 183 0.0079
300 NECROSIS 44 0.0079
301 AUTOIMMUNE HAEMOLYTIC ANAEMIA 27 0.0079
302 INTERSTITIAL LUNG DISEASE 380 0.0078
303 CARDIAC FAILURE ACUTE 52 0.0078
304 HEPATITIS B 47 0.0078
305 CARCINOEMBRYONIC ANTIGEN INCREASED 15 0.0077
306 ATYPICAL PNEUMONIA 23 0.0077
307 PULMONARY ALVEOLAR HAEMORRHAGE 43 0.0077
308 DEEP VEIN THROMBOSIS 490 0.0075
309 DUODENITIS 23 0.0075
310 WHITE BLOOD CELL DISORDER 20 0.0075
311 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 38 0.0075
312 CACHEXIA 38 0.0074
313 OESOPHAGEAL VARICES HAEMORRHAGE 16 0.0074
314 B-CELL LYMPHOMA 25 0.0074
315 ILEUS 91 0.0073
316 THERAPY NON-RESPONDER 329 0.0073
317 ESCHERICHIA URINARY TRACT INFECTION 31 0.0073
318 LEFT VENTRICULAR FAILURE 25 0.0073
319 ATRIAL THROMBOSIS 15 0.0072
320 BLOOD ALKALINE PHOSPHATASE INCREASED 180 0.0072
321 IMMUNE THROMBOCYTOPENIA 33 0.0072
322 PULMONARY EMBOLISM 684 0.0072
323 HEPATOCELLULAR INJURY 102 0.0072
324 LIVEDO RETICULARIS 15 0.0072
325 COLITIS 272 0.0072
326 GENERAL PHYSICAL HEALTH DETERIORATION 830 0.0072
327 PSEUDOMEMBRANOUS COLITIS 16 0.0072
328 HEPATIC FAILURE 216 0.0072
329 PLATELET COUNT DECREASED 763 0.0072
330 PNEUMOTHORAX 113 0.0071
331 JAUNDICE 190 0.0071
332 CHOLESTASIS 135 0.0070
333 BLOOD CHLORIDE DECREASED 18 0.0070
334 ACUTE PULMONARY OEDEMA 39 0.0069
335 VARICES OESOPHAGEAL 21 0.0069
336 PNEUMONIA VIRAL 22 0.0069
337 MULTIPLE ORGAN DYSFUNCTION SYNDROME 195 0.0069
338 PNEUMONIA FUNGAL 27 0.0068
339 HYPOKALAEMIA 315 0.0068
340 HICCUPS 56 0.0068
341 DISSEMINATED INTRAVASCULAR COAGULATION 96 0.0068
342 IMMUNE-MEDIATED ENTEROCOLITIS 25 0.0068
343 AMYLASE INCREASED 25 0.0068
344 BACTERIAL SEPSIS 22 0.0067
345 CHOLESTATIC LIVER INJURY 15 0.0067
346 HYPERCALCAEMIA 83 0.0067
347 ILEUS PARALYTIC 30 0.0067
348 RETINOPATHY 25 0.0067
349 CLOSTRIDIUM DIFFICILE COLITIS 71 0.0067
350 HAEMOGLOBIN ABNORMAL 43 0.0067
351 STAPHYLOCOCCAL SEPSIS 33 0.0067
352 BLOOD CULTURE POSITIVE 20 0.0067
353 HYPERVOLAEMIA 33 0.0067
354 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 50 0.0067
355 HYPOCALCAEMIA 122 0.0064
356 ESCHERICHIA INFECTION 53 0.0064
357 BLOOD ALBUMIN DECREASED 51 0.0064
358 CARDIOMYOPATHY 95 0.0064
359 BILIRUBIN CONJUGATED INCREASED 15 0.0064
360 TACHYARRHYTHMIA 16 0.0064
361 AGRANULOCYTOSIS 119 0.0064
362 LYMPHADENOPATHY 226 0.0064
363 METABOLIC DISORDER 37 0.0064
364 STRESS CARDIOMYOPATHY 37 0.0064
365 CYTOMEGALOVIRUS INFECTION REACTIVATION 28 0.0063
366 BRONCHOPULMONARY ASPERGILLOSIS 49 0.0063
367 TUMOUR HAEMORRHAGE 18 0.0063
368 GENERALISED OEDEMA 78 0.0063
369 HEPATITIS B REACTIVATION 20 0.0063
370 RASH MACULO-PAPULAR 140 0.0063
371 TYPE I HYPERSENSITIVITY 22 0.0062
372 PHLEBITIS 32 0.0062
373 HEPATOSPLENOMEGALY 16 0.0062
374 LYMPHADENITIS 15 0.0062
375 TROPONIN INCREASED 47 0.0062
376 CARBOHYDRATE ANTIGEN 125 INCREASED 21 0.0062
377 GLOMERULONEPHRITIS 15 0.0061
378 HYPONATRAEMIA 345 0.0061
379 LYMPHOCYTE COUNT DECREASED 108 0.0061
380 OVARIAN CANCER 56 0.0061
381 ASPARTATE AMINOTRANSFERASE INCREASED 322 0.0061
382 BLOOD DISORDER 48 0.0060
383 ALANINE AMINOTRANSFERASE INCREASED 367 0.0060
384 ERYSIPELAS 30 0.0060
385 DUODENAL ULCER 42 0.0059
386 PSEUDOMONAS INFECTION 51 0.0059
387 ELECTROLYTE IMBALANCE 69 0.0059
388 ATRIOVENTRICULAR BLOCK SECOND DEGREE 18 0.0059
389 CLOSTRIDIAL INFECTION 20 0.0059
390 HEPATIC CYST 20 0.0059
391 CHOLECYSTITIS 70 0.0059
392 COVID-19 PNEUMONIA 69 0.0058
393 CHRONIC GRAFT VERSUS HOST DISEASE 21 0.0058
394 HEPATITIS CHOLESTATIC 35 0.0058
395 HYPERAMMONAEMIA 29 0.0058
396 MONOCYTE COUNT INCREASED 21 0.0058
397 PYREXIA 1978 0.0057
398 INTESTINAL PERFORATION 64 0.0057
399 PNEUMONIA BACTERIAL 52 0.0057
400 IMMUNE THROMBOCYTOPENIC PURPURA 16 0.0057
401 NEOPLASM 65 0.0056
402 RESPIRATORY FAILURE 412 0.0056
403 LARGE INTESTINE PERFORATION 39 0.0056
404 VENTRICULAR HYPOKINESIA 18 0.0056
405 DUODENAL ULCER HAEMORRHAGE 16 0.0056
406 HYPOXIA 196 0.0056
407 UPPER GASTROINTESTINAL HAEMORRHAGE 93 0.0055
408 LEUKOCYTOSIS 100 0.0055
409 SCLERODERMA 20 0.0055
410 NEUTROPHIL COUNT INCREASED 56 0.0055
411 DERMATITIS EXFOLIATIVE GENERALISED 19 0.0055
412 HAEMATOCRIT DECREASED 108 0.0054
413 ACUTE CORONARY SYNDROME 45 0.0054
414 HEPATIC FUNCTION ABNORMAL 202 0.0054
415 RENAL TUBULAR NECROSIS 53 0.0054
416 ATRIAL FLUTTER 43 0.0054
417 CARDIAC DYSFUNCTION 20 0.0054
418 LIPASE INCREASED 41 0.0053
419 DRUG TOLERANCE DECREASED 15 0.0053
420 EJECTION FRACTION DECREASED 83 0.0053
421 ACUTE KIDNEY INJURY 796 0.0052
422 GUILLAIN-BARRE SYNDROME 25 0.0052
423 GAMMA-GLUTAMYLTRANSFERASE INCREASED 114 0.0051
424 HAEMOGLOBIN DECREASED 527 0.0051
425 PLATELET COUNT ABNORMAL 31 0.0051
426 OESOPHAGITIS 56 0.0051
427 EPSTEIN-BARR VIRUS INFECTION 32 0.0051
428 EXTRAVASATION 21 0.0051
429 HYPERURICAEMIA 21 0.0051
430 HAEMOPTYSIS 142 0.0051
431 DEVICE RELATED INFECTION 78 0.0051
432 CHRONIC LYMPHOCYTIC LEUKAEMIA 24 0.0051
433 C-REACTIVE PROTEIN INCREASED 184 0.0051
434 PROTEIN TOTAL DECREASED 19 0.0050
435 BACTERIAL INFECTION 94 0.0050
436 WHITE BLOOD CELL COUNT ABNORMAL 32 0.0050
437 PARONYCHIA 22 0.0050
438 MYOCARDITIS 57 0.0050
439 OSTEONECROSIS OF JAW 123 0.0050
440 NEPHROTIC SYNDROME 34 0.0050
441 HEPATITIS ACUTE 32 0.0049
442 HAEMOLYSIS 38 0.0049
443 LUNG NEOPLASM 21 0.0049
444 HEPATIC NEOPLASM 16 0.0049
445 LUNG INFECTION 76 0.0049
446 COLITIS ISCHAEMIC 33 0.0049
447 INFLAMMATORY MARKER INCREASED 24 0.0048
448 ACUTE RESPIRATORY FAILURE 93 0.0048
449 HYPOVOLAEMIA 28 0.0048
450 ATRIOVENTRICULAR BLOCK COMPLETE 32 0.0048
451 ANOREXIA 61 0.0047
452 HYPOGAMMAGLOBULINAEMIA 31 0.0047
453 TREATMENT FAILURE 388 0.0047
454 PULMONARY TUBERCULOSIS 20 0.0047
455 PULMONARY MASS 69 0.0046
456 ADRENAL INSUFFICIENCY 56 0.0046
457 STOMATITIS 279 0.0046
458 SUPRAVENTRICULAR TACHYCARDIA 44 0.0046
459 SINUS TACHYCARDIA 65 0.0046
460 DIVERTICULUM INTESTINAL 20 0.0046
461 CONGESTIVE CARDIOMYOPATHY 19 0.0046
462 BLOOD CREATININE INCREASED 297 0.0045
463 LOCALISED OEDEMA 21 0.0045
464 ABDOMINAL ABSCESS 20 0.0045
465 SPLENOMEGALY 53 0.0045
466 PURPURA 40 0.0045
467 DEHYDRATION 603 0.0045
468 PROTHROMBIN TIME PROLONGED 27 0.0045
469 WHITE BLOOD CELL COUNT DECREASED 488 0.0045
470 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 320 0.0045
471 MYOCARDIAL ISCHAEMIA 51 0.0045
472 ANGIOPATHY 25 0.0045
473 CANDIDA INFECTION 75 0.0044
474 ORAL CANDIDIASIS 58 0.0044
475 HYPERGLYCAEMIA 160 0.0044
476 GRANULOCYTOPENIA 25 0.0044
477 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 45 0.0044
478 CARDIOPULMONARY FAILURE 17 0.0044
479 ODYNOPHAGIA 26 0.0044
480 HAEMATURIA 149 0.0043
481 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22 0.0043
482 PATHOLOGICAL FRACTURE 22 0.0043
483 OEDEMA PERIPHERAL 527 0.0043
484 RENAL FAILURE ACUTE 183 0.0043
485 DRUG TOXICITY 58 0.0043
486 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 33 0.0042
487 PERONEAL NERVE PALSY 24 0.0042
488 PLEURISY 25 0.0042
489 SKIN MASS 28 0.0042
490 HYPOPHAGIA 107 0.0042
491 HEPATIC ENCEPHALOPATHY 39 0.0042
492 DRUG INTOLERANCE 403 0.0042
493 RENAL FAILURE CHRONIC 32 0.0042
494 CELLULITIS 209 0.0041
495 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 34 0.0041
496 CUTANEOUS VASCULITIS 15 0.0041
497 SPINAL CORD COMPRESSION 16 0.0041
498 HYPOTHYROIDISM 131 0.0041
499 RENAL IMPAIRMENT 344 0.0041
500 DRUG-INDUCED LIVER INJURY 128 0.0041
501 HYPERTHYROIDISM 59 0.0041
502 DERMATITIS 85 0.0041
503 FLANK PAIN 38 0.0040
504 TUBULOINTERSTITIAL NEPHRITIS 75 0.0040
505 CANDIDIASIS 16 0.0040
506 BODY TEMPERATURE INCREASED 81 0.0040
507 VASCULITIS 46 0.0039
508 ABDOMINAL PAIN 918 0.0039
509 OEDEMA 213 0.0039
510 PYELONEPHRITIS 34 0.0039
511 SKIN INFECTION 44 0.0039
512 INFECTION 567 0.0039
513 ARTHRITIS BACTERIAL 16 0.0039
514 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 213 0.0039
515 ISCHAEMIC STROKE 69 0.0039
516 CARDIAC FAILURE 307 0.0038
517 HYPERTHERMIA 29 0.0038
518 EPISTAXIS 282 0.0038
519 HYPERKALAEMIA 132 0.0038
520 PLATELET COUNT INCREASED 49 0.0038
521 MALNUTRITION 42 0.0038
522 HEPATITIS C 45 0.0037
523 PRODUCT USE IN UNAPPROVED INDICATION 921 0.0037
524 CHOLECYSTITIS ACUTE 21 0.0037
525 CYTOMEGALOVIRUS INFECTION 61 0.0037
526 ENCEPHALOPATHY 90 0.0037
527 ACUTE HEPATIC FAILURE 50 0.0037
528 ANAPHYLACTOID REACTION 15 0.0036
529 HEPATITIS 92 0.0036
530 DECREASED APPETITE 830 0.0036
531 OLIGURIA 22 0.0035
532 PAPILLOEDEMA 16 0.0035
533 GASTROINTESTINAL HAEMORRHAGE 295 0.0035
534 MENTAL STATUS CHANGES 98 0.0035
535 CEREBRAL INFARCTION 86 0.0035
536 HEPATIC PAIN 15 0.0035
537 HAEMATEMESIS 89 0.0035
538 HYPERTENSIVE CRISIS 39 0.0035
539 LEFT VENTRICULAR HYPERTROPHY 15 0.0035
540 ASPERGILLUS INFECTION 23 0.0035
541 SUDDEN DEATH 37 0.0035
542 ACUTE MYOCARDIAL INFARCTION 103 0.0035
543 PULMONARY FIBROSIS 67 0.0035
544 DEVICE OCCLUSION 49 0.0035
545 SENSORY LOSS 28 0.0035
546 DYSPNOEA EXERTIONAL 131 0.0035
547 BLOOD URIC ACID INCREASED 20 0.0035
548 PETECHIAE 36 0.0034
549 VOMITING 1616 0.0034
550 IMMOBILE 15 0.0034
551 ABDOMINAL TENDERNESS 17 0.0034
552 INTESTINAL OBSTRUCTION 129 0.0034
553 BLOOD LACTIC ACID INCREASED 18 0.0034
554 CLOSTRIDIUM DIFFICILE INFECTION 74 0.0034
555 TOXICITY TO VARIOUS AGENTS 570 0.0034
556 PNEUMONIA 1094 0.0034
557 RETINAL HAEMORRHAGE 24 0.0034
558 BLOOD UREA INCREASED 56 0.0033
559 BLOOD SODIUM DECREASED 63 0.0033
560 OFF LABEL USE 2910 0.0033
561 PANCREATITIS ACUTE 74 0.0033
562 TOXIC SKIN ERUPTION 33 0.0033
563 RALES 19 0.0033
564 HYPERTRIGLYCERIDAEMIA 19 0.0032
565 ANAPHYLACTIC REACTION 178 0.0032
566 DERMATITIS EXFOLIATIVE 16 0.0032
567 VISUAL FIELD DEFECT 23 0.0032
568 CARDIOMEGALY 39 0.0032
569 PRESYNCOPE 77 0.0032
570 TYPE 1 DIABETES MELLITUS 19 0.0032
571 WHITE BLOOD CELL COUNT INCREASED 121 0.0032
572 GASTROENTERITIS 46 0.0031
573 RED BLOOD CELL COUNT DECREASED 90 0.0031
574 HYDROCEPHALUS 17 0.0031
575 GASTRITIS 82 0.0031
576 LIVER DISORDER 138 0.0031
577 RENAL FAILURE 410 0.0031
578 NAIL DISORDER 27 0.0031
579 LUNG DISORDER 151 0.0031
580 ASTHENIA 1153 0.0031
581 ANAPHYLACTIC SHOCK 79 0.0031
582 COAGULOPATHY 51 0.0031
583 MELAENA 67 0.0030
584 BREATH SOUNDS ABNORMAL 15 0.0030
585 TOXIC EPIDERMAL NECROLYSIS 46 0.0030
586 ANURIA 26 0.0030
587 CHILLS 353 0.0030
588 ORAL DISORDER 22 0.0030
589 SHOCK 69 0.0030
590 NEUTROPHILIA 17 0.0030
591 PRODUCT PRESCRIBING ISSUE 65 0.0030
592 PULMONARY OEDEMA 133 0.0030
593 SHOCK HAEMORRHAGIC 24 0.0029
594 LIVER FUNCTION TEST ABNORMAL 85 0.0029
595 SKIN HYPERPIGMENTATION 25 0.0029
596 TRICUSPID VALVE INCOMPETENCE 23 0.0029
597 RESPIRATORY TRACT INFECTION 75 0.0029
598 STREPTOCOCCAL INFECTION 16 0.0029
599 ORTHOSTATIC HYPOTENSION 50 0.0029
600 STAPHYLOCOCCAL INFECTION 94 0.0028
601 GASTRIC ULCER 54 0.0028
602 URINARY RETENTION 94 0.0028
603 LIVER INJURY 69 0.0028
604 ATRIAL FIBRILLATION 271 0.0028
605 BLOOD MAGNESIUM DECREASED 24 0.0028
606 CONSTIPATION 605 0.0028
607 SKIN REACTION 39 0.0028
608 DERMATITIS BULLOUS 20 0.0028
609 PNEUMONIA ASPIRATION 69 0.0028
610 HAEMODYNAMIC INSTABILITY 21 0.0028
611 ACIDOSIS 21 0.0027
612 MOTOR DYSFUNCTION 28 0.0027
613 GENERALISED TONIC-CLONIC SEIZURE 45 0.0027
614 RESPIRATORY DISTRESS 75 0.0027
615 ILL-DEFINED DISORDER 165 0.0027
616 DECUBITUS ULCER 22 0.0027
617 TACHYCARDIA 239 0.0027
618 PERITONITIS 55 0.0027
619 MITRAL VALVE INCOMPETENCE 30 0.0026
620 HEPATOMEGALY 26 0.0026
621 BONE DISORDER 48 0.0026
622 ECCHYMOSIS 18 0.0026
623 HAEMORRHAGE INTRACRANIAL 39 0.0026
624 CYANOSIS 41 0.0026
625 DIARRHOEA 1674 0.0026
626 CIRCULATORY COLLAPSE 44 0.0026
627 LOWER GASTROINTESTINAL HAEMORRHAGE 19 0.0026
628 NAUSEA 2032 0.0026
629 DRUG ERUPTION 45 0.0025
630 VENTRICULAR FIBRILLATION 28 0.0025
631 GASTRIC HAEMORRHAGE 29 0.0025
632 MASS 35 0.0025
633 GANGRENE 15 0.0025
634 MULTI-ORGAN FAILURE 43 0.0025
635 NERVOUS SYSTEM DISORDER 77 0.0025
636 MUSCULOSKELETAL CHEST PAIN 38 0.0025
637 BRONCHOSPASM 35 0.0025
638 ABSCESS 39 0.0024
639 MYOPATHY 21 0.0024
640 GASTROINTESTINAL INFLAMMATION 19 0.0024
641 INTERNATIONAL NORMALISED RATIO INCREASED 69 0.0024
642 HEPATIC STEATOSIS 45 0.0024
643 URINE OUTPUT DECREASED 21 0.0024
644 INFUSION RELATED REACTION 159 0.0024
645 THROMBOSIS 192 0.0024
646 GRAND MAL CONVULSION 22 0.0024
647 SKIN ULCER 61 0.0024
648 GENERAL PHYSICAL CONDITION ABNORMAL 16 0.0024
649 TOOTH ABSCESS 24 0.0024
650 SKIN DISORDER 77 0.0023
651 AUTOIMMUNE HEPATITIS 16 0.0023
652 NODULE 30 0.0023
653 NO THERAPEUTIC RESPONSE 28 0.0023
654 HYPOTENSION 460 0.0023
655 SPINAL OSTEOARTHRITIS 20 0.0023
656 INTENTIONAL PRODUCT USE ISSUE 199 0.0023
657 HYPERTENSION 480 0.0023
658 STEVENS-JOHNSON SYNDROME 50 0.0022
659 DIARRHOEA HAEMORRHAGIC 21 0.0022
660 HEPATOCELLULAR CARCINOMA 17 0.0022
661 SYNCOPE 223 0.0022
662 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
663 FATIGUE 1707 0.0022
664 WOUND INFECTION 24 0.0022
665 LIVER FUNCTION TEST INCREASED 47 0.0022
666 PULMONARY HAEMORRHAGE 17 0.0022
667 DYSPNOEA 1226 0.0022
668 URINARY TRACT INFECTION 368 0.0022
669 BLOOD CALCIUM DECREASED 24 0.0021
670 HEMIPARESIS 36 0.0021
671 PULMONARY CONGESTION 28 0.0021
672 OPTIC NEURITIS 19 0.0021
673 NIGHT SWEATS 67 0.0021
674 TASTE DISORDER 42 0.0021
675 TACHYPNOEA 28 0.0021
676 ABDOMINAL PAIN LOWER 52 0.0021
677 NEURALGIA 50 0.0021
678 DRUG INEFFECTIVE 2705 0.0021
679 MOUTH HAEMORRHAGE 15 0.0020
680 MOUTH ULCERATION 43 0.0020
681 RECTAL HAEMORRHAGE 87 0.0020
682 TRANSFUSION 21 0.0020
683 BLOOD PRESSURE SYSTOLIC INCREASED 39 0.0020
684 CARDIAC ARREST 165 0.0020
685 HYPOKINESIA 29 0.0020
686 THERAPEUTIC RESPONSE DECREASED 121 0.0020
687 OXYGEN SATURATION DECREASED 112 0.0020
688 DYSURIA 73 0.0020
689 INFLAMMATION 102 0.0020
690 DELIRIUM 68 0.0020
691 HIP ARTHROPLASTY 30 0.0020
692 CARDIOGENIC SHOCK 28 0.0019
693 ULCER 31 0.0019
694 HYPERAESTHESIA 16 0.0019
695 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
696 RESPIRATORY RATE INCREASED 17 0.0019
697 BONE PAIN 112 0.0019
698 IMPAIRED GASTRIC EMPTYING 26 0.0019
699 DYSGEUSIA 141 0.0019
700 SKIN PLAQUE 16 0.0019
701 GASTROINTESTINAL INFECTION 17 0.0019
702 OSTEOMYELITIS 34 0.0019
703 PULMONARY HYPERTENSION 39 0.0019
704 PELVIC PAIN 34 0.0019
705 FISTULA 21 0.0019
706 SUBARACHNOID HAEMORRHAGE 19 0.0019
707 END STAGE RENAL DISEASE 34 0.0019
708 CARDIAC MURMUR 16 0.0018
709 DIALYSIS 26 0.0018
710 ERYTHEMA MULTIFORME 17 0.0018
711 GASTROINTESTINAL DISORDER 163 0.0018
712 DRUG EFFECT INCOMPLETE 66 0.0018
713 TRANSIENT ISCHAEMIC ATTACK 61 0.0018
714 ALOPECIA 355 0.0018
715 HYPOTONIA 18 0.0018
716 DEATH 1543 0.0018
717 QUALITY OF LIFE DECREASED 24 0.0018
718 HAEMODIALYSIS 15 0.0018
719 EMPHYSEMA 18 0.0018
720 DYSARTHRIA 67 0.0018
721 CONJUNCTIVITIS 33 0.0018
722 RHABDOMYOLYSIS 74 0.0018
723 PHARYNGITIS 22 0.0018
724 LETHARGY 102 0.0018
725 MUSCULAR WEAKNESS 200 0.0018
726 CONFUSIONAL STATE 282 0.0017
727 FUNGAL INFECTION 58 0.0017
728 ASPIRATION 19 0.0017
729 CEREBRAL HAEMORRHAGE 62 0.0017
730 ERYTHEMA 354 0.0017
731 DEAFNESS 45 0.0017
732 APPENDICITIS 16 0.0017
733 WEIGHT DECREASED 474 0.0017
734 DYSPHAGIA 161 0.0017
735 COUGH 471 0.0017
736 RASH 732 0.0017
737 SKIN LESION 46 0.0017
738 FACE OEDEMA 28 0.0017
739 CARDIO-RESPIRATORY ARREST 68 0.0016
740 WEIGHT FLUCTUATION 17 0.0016
741 HIATUS HERNIA 21 0.0016
742 PALLOR 44 0.0016
743 HEPATIC ENZYME INCREASED 110 0.0016
744 PARAESTHESIA 252 0.0016
745 CONDITION AGGRAVATED 487 0.0016
746 HERPES ZOSTER 92 0.0016
747 EOSINOPHILIA 28 0.0016
748 BREAST PAIN 17 0.0016
749 BLOOD COUNT ABNORMAL 24 0.0016
750 HAEMATOMA 41 0.0016
751 ORAL PAIN 35 0.0016
752 UPPER RESPIRATORY TRACT INFECTION 72 0.0016
753 OSTEONECROSIS 51 0.0016
754 UNRESPONSIVE TO STIMULI 40 0.0015
755 COVID-19 271 0.0015
756 ORAL HERPES 30 0.0015
757 OBSTRUCTIVE AIRWAYS DISORDER 17 0.0015
758 FOLLICULITIS 16 0.0015
759 COMPLICATION ASSOCIATED WITH DEVICE 22 0.0015
760 ANGINA PECTORIS 43 0.0015
761 DRUG INTERACTION 235 0.0015
762 IMMUNODEFICIENCY 22 0.0015
763 HAEMORRHAGE 154 0.0015
764 METABOLIC ACIDOSIS 47 0.0015
765 PSYCHOTIC DISORDER 43 0.0015
766 CHEST PAIN 268 0.0014
767 FLUID OVERLOAD 21 0.0014
768 CHROMATURIA 32 0.0014
769 HYPERSENSITIVITY 263 0.0014
770 MICTURITION URGENCY 16 0.0014
771 INFUSION SITE PAIN 18 0.0014
772 GINGIVAL BLEEDING 19 0.0014
773 CARDIAC FAILURE CONGESTIVE 110 0.0014
774 PERICARDITIS 23 0.0014
775 TOOTH INFECTION 18 0.0014
776 GASTROINTESTINAL PAIN 15 0.0014
777 DISORIENTATION 54 0.0014
778 RASH ERYTHEMATOUS 65 0.0014
779 APHASIA 41 0.0014
780 EPILEPSY 41 0.0013
781 PARALYSIS 19 0.0013
782 PULMONARY ARTERIAL HYPERTENSION 19 0.0013
783 RESPIRATORY DISORDER 39 0.0013
784 TOOTH EXTRACTION 16 0.0013
785 ADVERSE EVENT 118 0.0013
786 VENTRICULAR TACHYCARDIA 21 0.0013
787 ATAXIA 15 0.0013
788 TINNITUS 57 0.0012
789 FULL BLOOD COUNT DECREASED 25 0.0012
790 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 36 0.0012
791 ABDOMINAL DISTENSION 128 0.0012
792 HYPOGLYCAEMIA 59 0.0012
793 PRODUCTIVE COUGH 58 0.0012
794 VERTIGO 74 0.0012
795 BACK PAIN 282 0.0012
796 DEPRESSED LEVEL OF CONSCIOUSNESS 48 0.0012
797 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 63 0.0012
798 LOCAL SWELLING 21 0.0012
799 BREAST CANCER 112 0.0012
800 POST PROCEDURAL COMPLICATION 23 0.0012
801 DIPLOPIA 31 0.0012
802 DERMATITIS ALLERGIC 15 0.0012
803 MUSCULOSKELETAL PAIN 62 0.0012
804 PARAESTHESIA ORAL 17 0.0012
805 HAEMATOCHEZIA 65 0.0012
806 NEOPLASM MALIGNANT 78 0.0012
807 LUNG NEOPLASM MALIGNANT 48 0.0012
808 DIABETIC KETOACIDOSIS 28 0.0012
809 CENTRAL NERVOUS SYSTEM LESION 16 0.0012
810 RASH PRURITIC 63 0.0012
811 PRODUCT USE ISSUE 218 0.0012
812 CEREBROVASCULAR ACCIDENT 194 0.0011
813 CYSTITIS 36 0.0011
814 HAEMORRHOIDS 22 0.0011
815 IMPAIRED HEALING 37 0.0011
816 HYPOAESTHESIA 168 0.0011
817 HEPATIC CIRRHOSIS 21 0.0011
818 PANCREATITIS 59 0.0011
819 RENAL INJURY 33 0.0011
820 BLINDNESS 45 0.0011
821 BLOOD POTASSIUM DECREASED 33 0.0011
822 DIVERTICULITIS 30 0.0011
823 EAR PAIN 21 0.0011
824 POLLAKIURIA 45 0.0011
825 RETCHING 23 0.0011
826 MYALGIA 181 0.0011
827 DYSPHONIA 62 0.0011
828 SENSORY DISTURBANCE 17 0.0011
829 ARRHYTHMIA 50 0.0011
830 VISUAL ACUITY REDUCED 35 0.0011
831 SCAR 18 0.0011
832 BRADYCARDIA 55 0.0010
833 HYPERHIDROSIS 133 0.0010
834 RENAL DISORDER 48 0.0010
835 NECK PAIN 57 0.0010
836 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 26 0.0010
837 BLOOD POTASSIUM INCREASED 16 0.0010
838 PHOTOSENSITIVITY REACTION 16 0.0010
839 VAGINAL HAEMORRHAGE 42 0.0010
840 COMA 46 0.0010
841 PHOTOPHOBIA 18 0.0010
842 PAIN IN JAW 27 0.0010
843 ABDOMINAL PAIN UPPER 196 0.0010
844 LOWER RESPIRATORY TRACT INFECTION 43 0.0009
845 LOSS OF CONSCIOUSNESS 121 0.0009
846 BLISTER 53 0.0009
847 PRODUCT ADMINISTRATION ERROR 19 0.0009
848 RASH PAPULAR 21 0.0009
849 PRURITUS 360 0.0009
850 THROAT TIGHTNESS 25 0.0009
851 THERAPEUTIC PRODUCT EFFECT DECREASED 41 0.0009
852 CHOLELITHIASIS 30 0.0009
853 URINARY INCONTINENCE 27 0.0009
854 CONVULSION 52 0.0009
855 CHEST DISCOMFORT 92 0.0009
856 MUSCULOSKELETAL DISORDER 17 0.0009
857 EATING DISORDER 19 0.0009
858 SKIN EXFOLIATION 75 0.0009
859 PAIN 534 0.0009
860 CARDIOVASCULAR DISORDER 22 0.0009
861 PAIN IN EXTREMITY 255 0.0009
862 LACTIC ACIDOSIS 28 0.0009
863 DYSPEPSIA 83 0.0008
864 BLOOD PRESSURE DECREASED 56 0.0008
865 DIABETES MELLITUS 64 0.0008
866 MALAISE 364 0.0008
867 DIZZINESS 408 0.0008
868 FLUSHING 83 0.0008
869 FEELING HOT 50 0.0008
870 CHRONIC KIDNEY DISEASE 61 0.0008
871 CORONARY ARTERY DISEASE 24 0.0008
872 FRACTURE 15 0.0008
873 GASTRIC CANCER 20 0.0008
874 FEEDING DISORDER 16 0.0008
875 FLUID RETENTION 40 0.0008
876 FAECES DISCOLOURED 17 0.0008
877 DISCOMFORT 46 0.0008
878 WOUND 21 0.0008
879 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
880 HIP FRACTURE 24 0.0007
881 POOR QUALITY SLEEP 16 0.0007
882 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
883 GASTROOESOPHAGEAL REFLUX DISEASE 58 0.0007
884 HYPOACUSIS 31 0.0007
885 BLOOD PRESSURE INCREASED 110 0.0007
886 SWELLING 67 0.0007
887 DEPRESSED MOOD 37 0.0007
888 SEIZURE 80 0.0007
889 VISUAL IMPAIRMENT 85 0.0007
890 OSTEOPOROSIS 28 0.0007
891 MYOCARDIAL INFARCTION 117 0.0007
892 VISION BLURRED 91 0.0007
893 TREMOR 110 0.0007
894 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
895 RESTLESSNESS 24 0.0007
896 FLATULENCE 37 0.0007
897 ABASIA 16 0.0006
898 SINUSITIS 65 0.0006
899 SKIN DISCOLOURATION 29 0.0006
900 FALL 210 0.0006
901 ECZEMA 33 0.0006
902 INFLUENZA 70 0.0006
903 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
904 HEPATIC CANCER 15 0.0006
905 BRONCHITIS 46 0.0006
906 PERIPHERAL SWELLING 95 0.0006
907 GAIT DISTURBANCE 117 0.0006
908 OCULAR HYPERAEMIA 29 0.0006
909 SOMNOLENCE 123 0.0006
910 DEPRESSION 138 0.0006
911 AGITATION 44 0.0006
912 HEART RATE INCREASED 59 0.0006
913 OROPHARYNGEAL PAIN 55 0.0006
914 NEPHROLITHIASIS 27 0.0006
915 TREATMENT NONCOMPLIANCE 32 0.0006
916 RESPIRATORY ARREST 16 0.0006
917 HEADACHE 358 0.0006
918 CARDIAC DISORDER 53 0.0006
919 MOBILITY DECREASED 40 0.0006
920 BALANCE DISORDER 48 0.0006
921 LIMB DISCOMFORT 17 0.0005
922 DYSSTASIA 16 0.0005
923 ACCIDENTAL OVERDOSE 20 0.0005
924 INFLUENZA LIKE ILLNESS 45 0.0005
925 VIRAL INFECTION 18 0.0005
926 HEAD INJURY 17 0.0005
927 GASTRIC DISORDER 18 0.0005
928 ARTHRALGIA 216 0.0005
929 EMOTIONAL DISORDER 16 0.0005
930 LIP SWELLING 17 0.0005
931 DRY MOUTH 41 0.0005
932 DRY EYE 25 0.0005
933 ANGIOEDEMA 22 0.0005
934 OSTEOARTHRITIS 21 0.0005
935 RHINORRHOEA 32 0.0005
936 COGNITIVE DISORDER 23 0.0005
937 BLADDER CANCER 29 0.0005
938 DRY SKIN 65 0.0005
939 RASH MACULAR 17 0.0005
940 WEIGHT INCREASED 108 0.0005
941 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
942 ADVERSE DRUG REACTION 43 0.0005
943 INSOMNIA 126 0.0005
944 WHEEZING 28 0.0005
945 URTICARIA 77 0.0005
946 SPEECH DISORDER 24 0.0005
947 HOT FLUSH 34 0.0005
948 SWELLING FACE 28 0.0004
949 CATARACT 25 0.0004
950 ARTHRITIS 33 0.0004
951 NO ADVERSE EVENT 75 0.0004
952 BLOOD GLUCOSE INCREASED 77 0.0004
953 HALLUCINATION 30 0.0004
954 MEDICATION ERROR 22 0.0004
955 BLOOD CHOLESTEROL INCREASED 18 0.0004
956 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 68 0.0004
957 PALPITATIONS 44 0.0004
958 ABDOMINAL DISCOMFORT 62 0.0004
959 CONTUSION 35 0.0004
960 ANXIETY 103 0.0004
961 UNEVALUABLE EVENT 27 0.0004
962 THROAT IRRITATION 16 0.0004
963 EXPOSURE DURING PREGNANCY 22 0.0004
964 AMNESIA 23 0.0004
965 SUICIDE ATTEMPT 21 0.0003
966 ARTHROPATHY 19 0.0003
967 COLITIS ULCERATIVE 15 0.0003
968 THERAPY CESSATION 16 0.0003
969 EYE PAIN 17 0.0003
970 MATERNAL EXPOSURE DURING PREGNANCY 26 0.0003
971 INJURY 20 0.0003
972 MUSCLE SPASMS 52 0.0003
973 NASOPHARYNGITIS 48 0.0003
974 UNDERDOSE 19 0.0003
975 NASAL CONGESTION 15 0.0003
976 PROSTATE CANCER 20 0.0002
977 MIGRAINE 23 0.0002
978 MUSCULOSKELETAL STIFFNESS 21 0.0002
979 HOSPITALISATION 35 0.0002
980 SLEEP DISORDER 16 0.0002
981 FEELING ABNORMAL 51 0.0002
982 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
983 JOINT SWELLING 21 0.0002
984 OVERDOSE 37 0.0002
985 INCORRECT DOSE ADMINISTERED 38 0.0002
986 ASTHMA 18 0.0002
987 EMOTIONAL DISTRESS 19 0.0002
988 ILLNESS 16 0.0002
989 MEMORY IMPAIRMENT 20 0.0001
990 PRODUCT DOSE OMISSION ISSUE 17 0.0001
991 INJECTION SITE PAIN 15 0.0000